Shelley JambresicGroup Lead Science & Evaluation at Geistlich Pharma AGAdvisor
Profile
Shelley Jambresic is a Group Lead Science & Evaluation at Geistlich Pharma, responsible for clinical evaluation and clinical data interpretation of class III medical devices of animal origin. She is experienced in planning and conducting pre- and post-market clinical trials with medical devices and had the lead for implementation of MDR requirements in clinical processes at Geistlich Pharma. By training, Shelley Jambresic is a microbiologist and science communicator with extensive experience in medical and science writing.
Agenda Sessions
An Alternative Perspective: Research-Initiated Studies
, 16:15View Session